Browse Blog Posts by Tags

Also: Nearly 1 in 2 U.S. physicians report at least one symptom of burnout; and a decline in the number of circumcisions performed each year could actually raise health costs.

Here's what's making health news this morning: Court Rejects Patents on Medical Tests: (WSJ) The Supreme Court jolted the biotechnology industry with a unanimous ruling that threw out two medical-testing patents and suggested companies need to do more to prove their discoveries are really new...

This Merck division was only created about a year ago and Fujifilm is a recent addition to the biotech market with the purchase of another chemical company last year.  As mergers and acquisitions go with the use of business intelligence, companies are aligning themselves with “like” or similar technologies...

She does make some very good points here with bringing in additional revenue to allow the FDA to inspect more over seas manufacturing facilities.  She also states that branded companies as well as generic drug companies both need need more attention with inspections.  Currently in the US factories...

Sales have fallen and I guess even that big reward from Boston Scientific for 2 billion in 2010 was not enough to keep things rolling along here.  Apparently the stent business is growing in other places and sales are down to 2.5 billion from 4 billion just a few years ago.  Other companies...

This is a game or situation that Johnson and Johnson seems to be good at with their multitude of legal cases with stents.  This time they are on the losing end of the stick with a jury ruling they violated a patent.  The same researcher also won a case against Boston Scientific on his design...